Results 201 to 210 of about 66,840 (266)

[Novel clinical insights and frontier issues in alpha- fetoprotein-producing gastric cancer]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Luo B, Liu H, Xie W, Gong W.
europepmc   +1 more source

The Türkiye‐Qatar Partnership: From Ottoman Roots to Strategic Alliance

Middle East Policy, Volume 33, Issue 3, Autumn (Fall) 2026.
Abstract As Qatar, a small country in a strategic location, faced a pressure campaign from Gulf states in 2017, Türkiye expanded its military presence and provided support that proved crucial to Doha's ability to overcome the crisis. This demonstrated Türkiye's new grand strategy, its capacity to project influence into the Gulf, and its status as a ...
Ismail Köse, Fatma Alghussein
wiley   +1 more source

A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib. [PDF]

Cancer Med
Lee SW, Huang YJ, Tsai HJ, Lin YC, Chen CC, Lee TY, Chun-Peng Y.   +6 more
europepmc   +1 more source

Rethinking Political Islam in Iran: Contestation, Authority, and Reform

Middle East Policy, Volume 33, Issue 3, Autumn (Fall) 2026.
Abstract Political Islam in Iran is frequently portrayed in Western scholarship and policy discourse as a unified and rigid ideological system rooted in the 1979 Islamic Revolution. However, this article contends that it operates as a plural and internally contested field in which state‐directed, reformist‐clerical, and civic interpretations compete ...
Nagapushpa Devendra
wiley   +1 more source

Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy. [PDF]

J Hepatocell Carcinoma
Lin H, Ran F, Wu J, Huang C, Wu J, Liu C, Wang X, Ya H, Jiang K, Gu J, Yan M, Li S.   +11 more
europepmc   +1 more source

A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. [PDF]

Med Sci Monit
Lv X, Chen X, Ge Y, Si G, Li Y, Li X, Yuan X.   +6 more
europepmc   +1 more source

Management and Prognosis of HCC Patients With Elevated Tumor Markers but no Imaging Recurrence After Radiofrequency Ablation. [PDF]

Cancer Med
Moriyama M, Tateishi R, Matsushita Y, Yamada T, Nakatsuka T, Minami T, Sato M, Shiina S, Koike K, Fujishiro M.   +9 more
europepmc   +1 more source

Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. [PDF]

Oncol Res
Yu G, Ge W, Yao H, Bai X, Wu J, Wang Y, Bai J, Cui Y, Han J.   +8 more
europepmc   +1 more source

Integrating Network Pharmacology and Clinical Observation to Elucidate the Therapeutic Mechanisms of Yangzheng Xiaoji Decoction in Primary Liver Cancer. [PDF]

Int J Gen Med
Yang S, Liu R, Wen S, Wang Y, Tai N, Tian J.   +5 more
europepmc   +1 more source